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an Equilibrium between Cyclin B Synthesis
and Degradation
Emilie Ledan, Zbigniew Polanski,1 Marie-Emilie Terret, and
Bernard Maro2
Laboratoire de Biologie Cellulaire du De´veloppement, UMR 7622, CNRS, Universite´ Pierre
et Marie Curie, 9 quai Saint Bernard, 75252 Paris, France
Among the proteins whose synthesis and/or degradation is necessary for a proper progression through meiotic maturation,
cyclin B appears to be one of the most important. Here, we attempted to modulate the level of cyclin B1 and B2 synthesis
during meiotic maturation of the mouse oocyte. We used cyclin B1 or B2 mRNAs with poly(A) tails of different sizes and
cyclin B1 or B2 antisense RNAs. Oocytes microinjected with cyclin B1 mRNA showed two phenotypes: most were blocked
in MI, while the others extruded the first polar body in advance when compared to controls. Moreover, these effects were
correlated with the length of the poly(A) tail. Thus it seems that the rate of cyclin B1 translation controls the timing of the
first meiotic M phase and the transition to anaphase I. Moreover, overexpression of cyclin B1 or B2 was able to bypass the
dbcAMP-induced germinal vesicle block, but only the cyclin B1 mRNA-microinjected oocytes did not extrude their first
polar body. Oocytes injected with the cyclin B1 antisense progressed through the first meiotic M phase but extruded the first
polar body in advance and were unable to enter metaphase II. This suggested that inhibition of cyclin B1 synthesis only took
place at the end of the first meiotic M phase, most likely because the cyclin B1 mRNA was protected. The injection of cyclin
B2 antisense RNA had no effect. The life observation of the synthesis and degradation of a cyclin B1–GFP chimera during
meiotic maturation of the mouse oocyte demonstrated that degradation can only occur during a given period of time once
it has started. Taken together, our data demonstrate that the rates of cyclin B synthesis and degradation determine the
timing of the major events taking place during meiotic maturation of the mouse oocyte. © 2001 Academic Press
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In mammals, oocytes are arrested at the diplotene stage of
the first meiotic prophase. Meiotic maturation is controlled
through activation of the major cell cycle kinase, MPF
(M-phase promoting factor), composed of a catalytic sub-
unit, p34cdc2, and a regulatory subunit, cyclin B (Gautier et
l., 1990; Draetta et al., 1989; Labbe´ et al., 1989; Meijer et
al., 1989). MPF is activated at GVBD (germinal vesicle
breakdown). Then MPF activity rises until it reaches a
plateau at the end of the first meiotic M phase (M I) (Choi et
al., 1991; Verlhac et al., 1994). A transient decline in MPF
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400activity takes place during the transition between meiosis I
and meiosis II. MPF is reactivated rapidly to enter meiosis II
(M II) and is maintained at a high level during the meta-
phase II arrest.
The modulation of cyclin concentration by synthesis and
degradation is of central importance for the control of MPF
activity (Murray and Kirschner, 1989). The mitotic cyclins
are synthesized throughout the cell cycle and destroyed
during a short period, just before the metaphase–anaphase
transition (Evans et al., 1983). Cyclin B is degraded by the
ubiquitin pathway (Glotzer et al., 1991; Hershko et al.,
1991). In mouse oocyte, the synthesis of cyclin B increases
progressively during meiotic maturation, reaching its maxi-
mum at the end of the first meiotic M phase (Hampl and
Eppig, 1995a; Winston, 1997). Cyclin B is then degraded at
the time of polar body extrusion. Cycloheximide-treated
oocytes undergo GVBD normally, because of a preexisting
0012-1606/01 $35.00
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401Cyclin B Metabolism and Meiotic Maturationpool of cyclin B, but are unable to get a further increase in
MPF activity and to extrude the first polar body (Hampl and
Eppig, 1995b; Hashimoto and Kishimoto, 1988). When
protein synthesis is inhibited at the end of M I, the polar
body is normally extruded but MPF is not reactivated and
the oocyte enters interphase (Clarke and Masui, 1983;
Hashimoto and Kishimoto, 1988).
The role of cyclin B1 synthesis in the control of the
duration of meiotic maturation was shown in two strains of
mice, CBA/Kw and KE, which differ greatly in the timing of
meiotic maturation. CBA/Kw oocytes extrude the first
polar body about 7 h after GVBD while KE oocytes take
approximately 3–4 h longer. The rate of cyclin B1 synthesis
during M I is higher in CBA/Kw than in KE oocytes and
increasing cyclin B1 synthesis in KE oocytes speeds up first
polar body extrusion. Finally, the overall level of protein
synthesis and the amount of cyclin B1 messenger RNA are
identical in both strains, suggesting that cyclin B1 transla-
tion is controlled differently in these two strains (Polanski
et al., 1998). Among the different mechanisms that control
he expression of maternal mRNAs, polyadenylation has
een implicated in cyclin B1 translation in Xenopus and
mouse oocytes (Barkoff et al., 2000; de Moor and Richter,
1999; Tay et al., 2000).
Thus, it seems that the amount of cyclin B is tightly
regulated during meiotic maturation to control the timing
of the various event taking place during this period. We
designed experiments in which we attempted to modulate
the level of cyclin B synthesis by microinjecting different
sense and antisense cyclin B RNAs in immature mouse
oocytes in order to interfere with meiotic maturation. The
oocytes were then followed using a videomicroscope to
determine precisely the timing of meiosis resumption,
polar body extrusion (PBE), and entry into meiosis II.
Finally, using a human cyclin B1–GFP construct, cyclin B1
synthesis and degradation were directly observed in living
mouse oocytes.
MATERIALS AND METHODS
Collection and Culture of Oocytes
In this paper we used two strains of mice: CBA/Kw oocytes and
KE oocytes. We used KE oocytes to overexpress cyclin B and
CBA/Kw oocytes to inhibit cyclin B. As the level of cyclin B1 was
low in KE oocytes, it was easier to modulate the level of this one.
On the contrary, inhibition of the cyclin B1 level in CBA/Kw
oocytes, where H1 kinase activity is high, can give more significant
results than a strain where the level of cyclin B1 is already low.
To obtain immature oocytes arrested at prophase I of meiosis,
the ovaries were removed from 5- to 6-week-old KE or CBA/Kw
female mice (bred in the laboratory) or Swiss female mice (Ani-
malerie Spe´cialise´e de Villejuif, Centre National de la Recherche
Scientifique, France). The ovaries were transferred to prewarmed
(37°C) M2 medium, supplemented with 4 mg/ml bovine serum
albumin (BSA) (Whittingham, 1971) and 50 mg/ml dibutyryl cyclic
MP (dbcAMP), which prevents immature oocytes from undergo-
ng GVBD. The ovarian follicles were punctured to release the q
Copyright © 2001 by Academic Press. All rightnclosed oocytes, and immature oocytes displaying a germinal
esicle (GV) were collected (oocytes from all strains used in this
tudy have similar sizes). Samples for histone H1 kinase activity
ere collected in M2 medium 1 4 mg/ml polyvinylpyrrolidone
PVP) and frozen immediately at 270°C.
Metaphase II-arrested oocytes were recovered from mice super-
vulated by intraperitoneal injections of pregnant mare’s gonado-
rophin (PMSG; Intervet) and human chorionic gonadotrophin
hCG; Intervet) 48 h apart. Ovulated oocytes were released from the
mpullae of oviducts 13.5 h post-hCG. The cumulus cells were
ispersed by brief exposure to 0.1 M hyaluronidase (Sigma).
Immunofluorescence
The fixation and labeling of oocytes were performed as described
in Kubiak et al. (1993). We used the rat monoclonal antibody YL1/2
specific for tyrosinated a-tubulin (Kilmartin et al., 1982). As second
layer, we used a fluorescein-conjugated anti-rat antibody (Miles).
The chromatin was visualized using propidium iodide (Molecular
Probes; 5 mg/ml in PBS). Samples were observed with a Leica
TCS4D confocal microscope.
Immunoblotting
Samples were collected in sample buffer (Laemmli, 1970) and
heated to 100°C for 3 min. The proteins were separated by
electrophoresis in 10% polyacrylamide (ratio acrylamide/
bisacrylamide, 100/1) containing 0.1% SDS and electrically trans-
ferred to nitrocellulose membranes (Schleicher & Schuell; pore
size, 0.45 mm). Following transfer and blocking for 2 h in 3%
skimmed milk in 10 mM Tris (pH 7.5)/140 mM NaCl (TBS)
containing 0.1% Tween 20, the membrane was incubated over-
night at 4°C with the anti-cyclin B1 antibodies (Serotec, 1:500)
diluted in blocking solution. After three washes of 10 min each in
0.1% Tween 20/TBS, the membrane was incubated for 1 h at room
temperature with an anti-rabbit antibody conjugated to horseradish
peroxidase (Amersham) diluted 1:1000 in 3% skimmed milk in
0.1% Tween 20/TBS. The membrane was washed three times in
TBS/Tween and then processed using the Super Signal (Pierce)
detection system.
Kinase Activity
Histone H1 kinase activity was determined as described by Fe´lix
et al. (1989) in HK buffer (80 mM b-glycerophosphate, 20 mM
EGTA, pH 7.3, 15 mM MgCl2, 1 mM DTT, 1 mM PMSF, 10 mg/ml
leupeptin, 10 mg/ml pepstatin, 10 mg/ml aprotinin) using exogenous
histone H1 (HIII-S from calf thymus, Sigma) as the substrate.
Samples containing the oocytes in medium M2 1 PVP were lysed
by freezing and thawing three times, diluted twice in two times
concentrated HK buffer, and incubated for 15 min at 37°C in the
presence of 3.3 mg/ml histone H1, 1 mM ATP, and 0.25 mCi/ml
[32P]ATP (Kubiak et al., 1991).
The kinase reaction was stopped by adding 23 sample buffer
Laemmli, 1970) and boiling for 3 min. The samples were then
nalyzed by electrophoresis in 15% polyacrylamide gels containing
.1% SDS followed by autoradiography.
The autoradiographs were digitized using an Agfa Arcus Plus
canner and the kinase activity present in each sample was
uantified using NIH Image (v. 1.60) analysis software.
s of reproduction in any form reserved.
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402 Ledan et al.Plasmids
Plasmids for sense mRNAs. The full-length cDNA encoding
the mouse cyclin B1 (Chapman and Wolgemuth, 1992) was sub-
cloned from pBluescript SK(2) into pSP64(A) vector (30 A residues)
(Promega) as follows. The cDNA was amplified by PCR (advantage
2 PCR, Clontech) with a 59 primer (59-tagcttctctagacacga-
ggtggatagccagag-39) and a 39 primer (59-tagcggatccaaaatgagaag-
cacaacct-39). The resulting PCR was digested with XbaI and
amHI and ligated at the XbaI and BamHI sites of pSP64(A).
The plasmid containing the human cyclin B1–Mm GFP cDNA
as been previously described (Hagting et al., 1998). It was linear-
ized by SfiI and the 39-overhang was further filled with T4 DNA
polymerase. This plasmid allows in vitro transcription of the
human cyclin B1–GFP using T3 RNA polymerase.
Plasmids for antisense RNAs. To obtain the clone correspond-
ing to the 59 portion of the cyclin B1 mRNA (pBluescript cyclin B1
59), a 406-pb EcoRI–HindIII fragment (position 1 to 406) was cloned
between the EcoRI and HindIII sites of pBluescript SK(2) vector
(Stratagene).
The open reading frame (ORF) portion of cyclin B1, a 582-bp
EcoRI–EcoRV fragment (position 1–583), was cloned between
EcoRI and EcoRV. By linearization at the SmaI position, we could
in vitro transcribe a 400-pb fragment (pBluescript cyclin B1 ORF).
pRN3Mos was constructed by RT-PCR amplification from
mouse ovaries. Total RNA was extracted using RNeasy mini-kit
(Qiagen) and 500 ng of RNA was treated with 2 U of RQ1 DNase
(Promega) for 20 min at 37°C and then heated for 5 min at 85°C.
First-strand cDNA synthesis was then performed with 50 U of
MMuLV Superscript (Life Technologies) using 2.5 mM random
examer (pdN6, Pharmacia)/1 mM dNTPs (Promega), in 10 mM
ris–HCl, pH 8.3, 5 mM MgCl2, and 50 mM KCl for 1 h at 37°C,
ollowed by 5 min at 95°C. The PCR amplification was then
erformed on 50 ng of cDNA using 59-gatcagatctcaccat-
ccttcgcctctaagcc and 59-gatcgaattctcagcctagtgcccctcggaaag prim-
rs. The 1-kb PCR product was then digested by BglII/EcoRI and
loned into pRN3 (Brunet et al., 1998).
RNA Synthesis
To obtain cyclin B1 and B2 mRNAs with a long poly(A) tail
(A(n)), pBluescript vectors containing the full-length cyclin B1 or B2
cDNAs were linearized with XhoI and in vitro transcribed with T3
NA polymerase to produce capped mRNA (mMessage mMachine,
mbion). The cyclin B1 and B2 mRNAs were polyadenylated in
itro by incubation in a polyadenylation mixture: 250 mM NaCl,
0 mM Tris, 10 mM MgCl2, 100 mg/ml BSA, 2 mM DTT, 1 U/ml
NAsin (Promega), 100 mM ATP, 2.5 mM MnCl2, and 0.05 U/ml
PolyApolymerase (Pharmacia Biotech) for 37°C as described in
Vassalli et al. (1989). The reaction was stopped by 25 mM EDTA.
To produce cyclin B1 mRNA with a short poly(A) tail (A(30)) or
with no poly(A) tail (A(0)), we linearized pSP64(A) vector contain-
ing the full-length cyclin B1 with EcoRI and BamHI, respectively.
Capped mRNAs were synthesized with SP6 RNA polymerase
(mMessage mMachine, Ambion).
The full-length cyclin B1 or B2 antisense RNAs were linearized
at the EcoRI position of pBluescript vectors containing cyclin B1 or
B2 cDNAs. The pBluescript cyclin B1 59 portion and the pBlue-
script cyclin B1 ORF were linearized with EcoRI and SmaI, respec-
tively. The two antisense mRNAs against the 39 portion were
obtained by linearization at the SphI (194 pb) and the HincII (468
pb) positions. All antisense RNAs were synthesized with T7 RNA
polymerase (Ambion).
Copyright © 2001 by Academic Press. All rightAll samples were extracted with the RNeasy Kit (Qiagen) and
resuspended in injection buffer (10 mM Tris, pH 7.4). The concen-
tration of RNA was given in arbitrary units.
Microinjection
The in vitro synthesized sense and antisense RNAs were micro-
injected into the cytoplasm of GV oocytes using an Eppendorf
pressure microinjector and sterile pipets. About 10 pl of the RNA
solution containing around 0.5–1 mg/ml was injected per oocyte. We
roposed to define the concentration in arbitrary units (A.U.). Five
rbitrary units was the maximal concentration. The oocytes were
ept in M2 medium supplemented with dbcAMP during the
njection period. In certain experiments microinjected oocytes
ere maintained during 15 h in dbcAMP. The resumption of
eiotic maturation was triggered by removal of the injected
ocytes from the dbcAMP-containing medium. They were then
ultured in M2 medium under paraffin oil at 37°C, in an atmo-
phere of 5% CO2 in air.
RT-PCR Assay
Oocytes were collected in H2O treated with 0.1% diethyl pyro-
carbonate (H2O–DEPC) and stored at 280°C. Samples correspond-
ng to 50 oocytes in 10 ml were lysed by freezing and thawing. The
genomic DNA from 5 oocytes was digested by adding 2 U of RQ1
DNase (Promega) in 20 ml of the reverse transcriptase mix (10 mM
Tris–HCl, pH 8.3, 5 mM MgCl2, 50 mM KCl, 1 mM each dNTPs
Promega), 2.5 mM random hexamer (pd(N)6, Pharmacia) and 20 U
f RNase inhibitor (RNAsin, Promega) and incubating at 37°C for
0 min. The reaction was stopped by heating to 85°C for 5 min.
hen, the samples were supplemented with 50 U of SuperScript
NAse H–reverse transcriptase (Gibco BRL) to synthesize the
DNA. After 1 h of incubation at 37°C, the reaction was stopped by
eating to 95°C for 5 min. PCR amplification was performed in the
ame tube in a final volume of 50 ml containing 10 mM Tris–HCl,
H 8.3, 2.5 mM MgCl2, 50 mM KCl, 1 mM 59-specific primer, 1 mM
39-specific primer (59-actccctgcttcctgttat-39 and 59-aaaatgagaag-
tcacaacc-39 for cyclin B1; 59-gctagattttggaggagccatggc-39 and 59-
ctagggatccacggaattagacaa-39 for cyclin B2), and 2.5 U of Taq poly-
merase (Perkin–Elmer). Samples were denatured at 94°C for 3 min,
then subjected to 40 cycles of amplification (94°C, 1 min; 55°C, 1
min; 72°C, 1 min), and finally incubated for 10 min at 72°C.
Thirteen microliters of the amplified mixture was run on 2%
agarose gels. The gels were stained with ethidium bromide (5
mg/ml) and photographed under UV illumination.
Time-Lapse Fluorescence Imaging and Analysis
Microinjected oocytes were cultured under paraffin oil in a
specially designed chamber at 38°C. Oocytes were observed using a
motorized inverted microscope (Leica) coupled to a high-sensitivity
CCD camera (Micromax Princeton) and connected to a computer
that controls the different preestablished parameters (Metamorph).
Acquisitions were performed using phase contrast to follow oocyte
maturation (illumination, 50 ms). The acquisitions were performed
every 10 min.
For human cyclin B1–GFP mRNA-microinjected oocytes, acqui-
sitions were performed alternatively using phase contrast (illumi-
nation, 50 ms) and epifluorescence to follow cyclin B1 fluorescence
(3-s illumination using a log 1 neutral density filter). The acquisi-
tions were performed every 20 min. Images were analyzed using
s of reproduction in any form reserved.
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403Cyclin B Metabolism and Meiotic MaturationNIH Image. The area to be measured was drawn by hand on the first
image of a series and reproduced on each successive image. The
sum of pixel intensities was calculated in the area of interest for
each image.
RESULTS
Cyclin B1 Induces Meiosis Resumption in the
Presence of dbcAMP
To assay the role of cyclin B1 in the first event of meiotic
maturation we overexpressed cyclin B1 by microinjecting
cyclin B1 mRNA with a long poly(A) tail of about 150–300
adenosine residues after polyadenylation in vitro (Worm-
ington, 1991) in KE oocytes. The microinjected oocytes
resumed meiosis as the controls (73 6 15.7% versus 73 6
15.5%), but when we left the oocytes for a long time in
dbcAMP, the cyclin B1-A(n) microinjected mRNA was able
to induce GVBD in the presence of this inhibitor medium
(Table 1). After 5 h of culture in the presence of dbcAMP,
GVBD took place in 28% (in 36.82% 10 h later) of the
oocytes injected with cyclin B1-A(n). This suggests that
cyclin B1 synthesis may regulate GVBD, although it is
dispensable (Stern et al., 1972; Wassarman et al., 1979).
Then, we microinjected cyclin B1 mRNA with shorter
oly (A) tails: cyclin B1-A(30) had a short poly(A) tail (30
denosines residues) and cyclin B1-A(0) had no poly(A) tail.
he oocytes microinjected with these two forms of mRNA
esumed meiosis as the controls but, in contrast to the
yclin B1-A(n) mRNA-injected oocytes, they remained ar-
ested at the GV stage in the presence of dbcAMP. Thus,
olyadenylation seems to control the level of cyclin B1
ynthesis since only the oocytes microinjected with the
yclin B1-A(n) were able to synthesize enough cyclin B1 to
llow the formation of a small amount of active MPF able to
rigger GVBD. This was confirmed by immunoblot analysis
hen we observed that the amount of cyclin B1 present in
he oocyte increased with the length of the poly(A) tail of
TABLE 1
Effect of Cyclin B1 mRNA Injection on Meiosis Resumption
and First Polar Body Extrusion in KE Oocytes in Medium
Containing dbcAMP
Microinjected mRNA
% GVBDa
(mean 6 SD)
% PBEa
(mean 6 SD) n (Expt)b
Control (none) 0 0 232 (7)
Cyclin B1-A(0) 0 0 116 (4)
Cyclin B1-A(30) 0 0 24 (1)
Cyclin B1-A(n) 36 6 6.3 16.7 6 3.8 277 (6)
a Using the nonparametric Mann–Whitney test.
b Number of oocytes. Number of experiments in each group is
iven in parentheses.he injected mRNA (Fig. 1).
Copyright © 2001 by Academic Press. All rightCyclin B1 Controls the Timing of the First M
Phase and Polar Body Extrusion through the Level
of Cyclin B1 Translation
The length of the poly(A) tail seemed to control the level
of cyclin B1 synthesis. First, we followed first polar body
extrusion in KE oocytes microinjected with the different
cyclin B1 mRNAs that were immediately removed from the
dbcAMP-containing medium. Two phenotypes were ob-
served depending on the size of the poly(A) tail (Table 2).
Many oocytes were blocked in M I, depending on the length
of the poly(A) tail: the longer the poly(A) tail the more M I
is blocked. The others bypassed this block and extruded
their polar bodies earlier than did the controls. This ad-
vance was correlated with the length of the poly(A) tail
(Table 2): the longer the poly(A) tail, the earlier the PBE.
Microinjection of an unrelated mRNA (ezrin) did not influ-
ence significantly the timing of polar body extrusion (Table
2).
Most oocytes that broke down their GV in the presence of
dbcAMP were unable to extrude their first polar body (Table
1) and were arrested at the metaphase stage (Fig. 2). The
oocytes injected with the cyclin B1-A(n) mRNA that re-
mained blocked at the GV stage after 15 h in dbcAMP
underwent GVBD only after dbcAMP removal and extruded
their polar bodies (PB) in a lower proportion when compared
to controls (31% versus 93%). These experiments suggest
that the higher the cyclin B1 level was, the more important
the M I block. This block was likely due to the saturation of
the cyclin degradation machinery (Holloway et al., 1993;
Van der Velden and Lohka, 1993; Luca et al., 1991).
To test this hypothesis, we attempted to increase the
activity of the cyclin B1 degradation machinery using
ethanol treatment, a procedure used to parthenogenetically
activate mouse oocytes. Oocytes injected with cyclin B1-
A(n) mRNA that were blocked in dbcAMP overnight were
removed from dbcAMP and separated into two groups. In
the control group that was not treated with ethanol, 29.6 6
9.5% of the oocytes extruded their PB. The control oocytes
that did not extrude their PB were blocked in M I (Fig. 3A)
with paired homolog chromosomes (Fig. 3B). Of the oocytes
treated with ethanol at the normal time of PBE (10 h after
FIG. 1. Cyclin B1 levels in KE oocytes after cyclin B1-A(0) and
cyclin B1-A(n) mRNA microinjection. C, control oocytes; A(0),
cyclin B1-A(0) mRNA-microinjected oocytes; A(n), cyclin B1-A(n)
mRNA-microinjected oocytes. Lysates of KE oocytes (collected 4 h
after GVBD) were analyzed by immunoblotting using anti-cyclin
B1 antibodies (all samples contained 42 oocytes).
s of reproduction in any form reserved.
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404 Ledan et al.GVBD) 69 6 23.5% extruded their polar bodies and had
monovalent chromosomes (Figs. 3C and 3D). The difference
observed was statistically significant (P 5 0.008). This
experiment suggests that the M I arrest induced by cyclin
B1 overexpression is likely due to the large store of cyclin
B1 present in the oocyte. The cyclin degradation machinery
would be unable to degrade enough cyclin B1 to allow a
sufficient drop in MPF activity and thus PBE.
To confirm the incapacity of cyclin B1 to be degraded at
a sufficient level to allow the exit of the first M phase, we
microinjected a human cyclin B1–GFP mRNA (Clute and
Pines, 1999; Hagting et al., 1998) in GV mouse oocytes to
follow the synthesis and degradation of this protein during
maturation. We chose Swiss mouse oocytes because their
viability is not impaired by UV illumination. First we
checked that the effects on maturation induced by micro-
injection of the human cyclin B1–GFP mRNA were identi-
cal to those induced by the mouse cyclin B1 mRNA:
oocytes microinjected with human cyclin B1–GFP mRNA
underwent GVBD in dbcAMP (25% in the first hour); once
TABLE 2
Effect of Cyclin B1 mRNA Injection on Meiosis Resumption and F
Microinjected mRNA
Time of PBE
(mean 6 SD)
% PB
(mean 6
Control (none) 10.6 6 0.9 82.8 6 1
Cyclin B1-A(0) 9.8 6 1.1 74.3 6
Cyclin B1-A(30) 9.6 6 0.8 56 6 2
Cyclin B1-A(n) 8.8 6 1.7 39.8 6
Ezrin 10.9 6 1.3 77 6
Note. The oocytes were washed from dbcAMP just after the inje
a Using the nonparametric Mann–Whitney test.
b Number of oocytes. Number of experiments in each group is g
FIG. 2. Organization of microtubules and chromosomes in KE
oocytes after cyclin B1-A(n) mRNA injection. Oocytes were fixed
8 h after PBE in controls. (A) Uninjected oocytes were blocked in M
II. (B) Cyclin B1-A(n) mRNA-microinjected oocytes were blocked in
M I with no segregation of the homolog chromosomes. Microtu-
bules are shown in green and chromosomes in red.
Copyright © 2001 by Academic Press. All rightreleased from the inhibitor, only part of them extruded their
first polar bodies (54% vs 83% for the noninjected oocytes).
We concluded that human cyclin B1–GFP could be used to
follow the metabolism of cyclin B1 in mouse oocyte.
The fluorescence signal of the cyclin B1–GFP in oocytes
that extruded their polar bodies increased during the first
5 h until it reached a plateau (Figs. 4A and 4B). Then the
fluorescence signal dropped to 20% during the following
2 h. The polar body was extruded 20 min before the
fluorescence signal reached its minimum. The signal in-
creased again to reach a stable level during the M II arrest,
during which equilibrium between cyclin synthesis and
degradation takes place (Kubiak et al., 1993).
In oocytes that did not extrude the first polar body (Fig.
C), the cyclin B1–GFP behavior was identical during the 6
rst h, but its degradation was less efficient (40% slower
ate of degradation) and less complete (40% of the maxi-
um amount left versus 20%) than in the oocytes that
xtruded their polar bodies. These observations suggest to
s that the cyclin degradation can only take place during a
iven period of time. If at the end of this period, not enough
yclin B1 has been degraded, oocytes are unable to exit from
he first meiotic M phase.
Microinjection of Cyclin B1 Antisense Speeds Up
PBE and Inhibits Entry into M II
In an attempt to inhibit cyclin B1 synthesis in mouse
oocytes, we microinjected a mouse cyclin B1 antisense
mRNA into the cytoplasm of CBA/Kw oocytes at the GV
stage. The microinjected oocytes underwent GVBD nor-
mally (Table 3) and extruded their first polar bodies like the
control oocytes (Table 3), although PBE was slightly accel-
erated (6.44 6 0.1 h after GVBD for the cyclin B1 antisense
vs 7.67 6 0.98 h for the controls; P , 0.0001; Table 4).
However, in contrast to the control oocytes that were
arrested in M II, the microinjected oocytes entered inter-
phase as shown by the formation of a pronucleus 3–4 h after
PBE (Fig. 5) in a dose-dependant manner (Fig. 6).
Polar Body Extrusion in KE Oocytes in Cultured Medium
n (Expt)b
Pa (time of PBE)
Control Cyclin B1-A(n)
84 (6) ,0.0001
41 (3) ,0.0001 0.003
16 (2) ,0.0001 0.009
22 (3) ,0.0001
21 (2) NS ,0.0001
.
in parentheses.irst
E
SD)
8.4
7.6
4.6
1.4
8.5
ctionWhen MPF activity was assessed in microinjected oo-
s of reproduction in any form reserved.
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405Cyclin B Metabolism and Meiotic Maturationcytes, we observed that the rise in H1 kinase activity during
the first meiotic M phase was similar in microinjected and
control oocytes (Fig. 7A), while it was not reactivated after
PBE in microinjected oocytes (Fig. 7B). This suggested that
cyclin B was synthesized during the first meiotic M phase
despite the presence of the antisense. However, the anti-
sense was able to abolish cyclin B1 synthesis at the end of
FIG. 3. Effect of ethanol treatment on M I blocked oocytes.
mmature oocytes from KE strains were microinjected with cyclin
1-A(n), kept for 15 h in dbcAMP, and then washed and cultured in
2 medium. Twelve hours after GVBD the oocytes that did not
xtrude their first polar bodies were treated with freshly prepared
% ethanol (C, D) for 6.5 min. Then alcohol was carefully removed
y washing oocytes in M2 medium. Thirty minutes later, the first
olar bodies were extruded (A, B) in non-ethanol-treated oocytes.
ocytes were fixed 4 h after ethanol treatment. The chromosomes
ere stained with propidium iodine (B, D).the first meiotic M phase, since MPF was not reactivated.
Copyright © 2001 by Academic Press. All righthis was confirmed when the amount of cyclin B1 present
n the oocytes after cyclin B1 antisense microinjection was
robed by immunoblotting 6 h after GVBD (just before PBE)
nd the amount of cyclin B1 had already dropped to a low
evel in antisense-microinjected oocytes (Fig. 8A). When
egradation was inhibited by nocodazole a similar amount
f cyclin B1 was observed in both groups (Fig. 8B). Taking
nto account the low sensitivity of this assay, this may
uggest that the cyclin B1 antisense had little effect on
yclin B1 synthesis during M I but was able to speed up
egradation, likely through inhibition of cyclin B1 synthe-
is.
This lack of effect of the cyclin B1 antisense during the
rst meiotic M phase could be due to the synthesis of
nother cyclin B, cyclin B2, that could compensate for the
bsence of cyclin B1 synthesis. When oocytes were micro-
njected with a mouse cyclin B2 antisense mRNA, they
nderwent GVBD and were blocked in M II after PBE as
ontrols (Table 4 and Fig. 6), suggesting that cyclin B2 was
ot required for PBE and MPF reactivation. Finally to check
hether the synthesis of one cyclin was able to compensate
or the inhibition of the synthesis of the other cyclin was
ble to compensate for the inhibition of the synthesis of the
ther cyclin, we microinjected both cyclin B1 and B2
ntisenses. GVBD and PBE took place normally and the
icroinjected oocytes entered interphase, similar to those
njected with the cyclin B1 antisense alone (Table 3).
These observations suggest that the cyclin B1 antisense
RNA has no or little effect on cyclin B1 synthesis during
he first part of meiotic maturation, although it speeds up
BE and blocks the MPF reactivation required for entry into
he second meiotic M phase.
The acceleration of PBE could be due to the absence of
yclin synthesis that normally takes place during the MI/
II transition. The synthesis of cyclin B that occurs simul-
aneously with its degradation would delay the time at
hich MPF activity drops to a level low enough to allow the
etaphase/anaphase transition.
To test this hypothesis, we cultured CBA/KW oocytes in
uromycin to block protein synthesis (including cyclin B
ynthesis). When 10 mg/ml puromycin was added 6 h after
VBD (about 1.5 h before PBE) the first polar body was
xtruded 20 min earlier than in controls (7.12 6 0.38 (n 5
1) for puromycin vs 7.41 6 0.46 (n 5 50) for controls; P ,
.002). This reinforces the hypothesis that inhibition of
yclin B1 synthesis at the end of the first meiotic M phase
ccelerates polar body extrusion.
Cyclin B1 mRNAs Are Protected Until the End of
the First Meiotic M Phase
In the previous experiments, the cyclin B1 antisense
seems to be able to inhibit cyclin synthesis only at the end
of the first meiotic M phase, suggesting that it is not able to
interfere with the cyclin B1 mRNA before that time.
However, a few possible technical problems could be re-
sponsible for this effect.
s of reproduction in any form reserved.
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cytoplasm could delay the interaction between the anti-
sense and the mRNA. When we allowed the antisense to
FIG. 4. Live imaging of cyclin B1–GFP in maturing swiss mou
icroinjected with cyclin B1–GFP cultured on the microscope stag
rder of the panels is from left to right and from top to bottom. (B,
aturation. The fluorescence was measured every 20 min and the
ocyte. Data (mean 6 SD) from 16 oocytes that extruded their firs
graphs. Oocytes from both groups were observed simultaneous
microinjection.diffuse in GV-arrested oocytes before releasing the dbcAMP c
Copyright © 2001 by Academic Press. All rightlock for various periods of time (2, 4, and 15 h), there was
o difference in the effect of the antisense: microinjected
ocytes extruded their polar bodies about 1.25 h before the
ocytes. (A) Fluorescence and transmission images of an oocyte
ughout meiotic maturation. Images were taken every 20 min. The
emiquantitative analysis of the fluorescence signal during meiotic
s of fluorescence were normalized to the maximum value for each
ar bodies (B) and 13 oocytes that did not (C) were used to plot the
der the videomicroscope. Oocytes were washed just after these o
e thro
C) S
level
t pol
ly unontrols and then formed pronuclei (not shown).
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407Cyclin B Metabolism and Meiotic MaturationSecond, the large size (1.5 kb) of the full-length cyclin
B1 antisense could make the hybridization of the anti-
sense with the endogenous cyclin B1 mRNA difficult.
Therefore, we synthesized antisenses directed against
three regions of the cyclin B1 mRNA: The 59 region (0.4
kb), part of the coding region (0.4 kb), and the 39 region
0.5 and 0.2 kb) of the cyclin B1 mRNA (Fig. 9A). All these
horter antisense mRNAs had similar effects: the micro-
njected oocytes extruded their polar bodies and formed
ronuclei, as did the oocytes injected with the full-length
ntisense (Fig. 9B).
Third, the site of injection (cytoplasm or nucleus) could
odulate the effects of the antisense mRNAs. Microinjec-
ion of two different antisense mRNAs (1.5 kb (full length)
nd 0.5 kb 39 region) in the nucleus of CBA/Kw oocytes gave
he same phenotype as the oocytes microinjected in the
ytoplasm (not shown).
Finally, to confirm that the absence of inhibition of
yclin B1 translation during the first part of the first
eiotic M phase is due to a specific masking of the cyclin
TABLE 3
Effect of Cyclin B1 and B2 Antisense mRNAs on Meiotic
Maturation in CBA/Kw Oocytes
Microinjected
antisense
mRNA
% GVBD
(mean 6 SD)
% PBE
(mean 6 SD)
% Interphase
(mean 6 SD)
n
(Expt)a
Control (none) 85 6 10.4 87 6 10.1 0 315 (9)
yclin B1 64 6 16.6 72 6 14.3 85.5 6 12.9 109 (4)
yclin B2 81 6 7.8 79 6 11.9 0 33 (3)
yclin B1 1 B2 69.5 6 9.9 90 6 14.4 73.8 6 19.9 21 (2)
Note. The CBA/Kw oocytes were injected at the GV stage with 5
.U. of antisense and were washed from dbcAMP medium 4–5 h
ater.
a Number of oocytes. Number of experiments in each group is
iven in parentheses.
ABLE 4
ffect of Cyclin B1 and B2 Antisense RNA Injection on the
iming of GVBD and PBE in CBA/Kw Oocytes
Microinjected
antisense RNA
Time of GVBD
Time of PBE
(hours after GVBD)
mean 6 SD n (Expt)a mean 6 SD n (Expt)a
Control (none) 1.8 6 0.6 132 (5) 7.8 6 1 92 (4)
Cyclin B1 1.8 6 0.5 51 (2) 6.4 6 0.7 49 (2)
Cyclin B2 1.7 6 0.5 27 (2) 7.1 6 0.8 23 (2)
Note. The CBA/Kw oocytes were injected at the GV stage with 5
A.U. of antisense and were washed 4–5 h later.
a Number of oocytes. Number of experiments in each group is
iven in parentheses. 0
Copyright © 2001 by Academic Press. All rightFIG. 5. CBA/Kw oocytes were microinjected with 5 a.u. of cyclin
B1 antisense RNA and observed 4 h after PBE. Control oocytes were
arrested in M II (A, C) and cyclin B1 antisense RNA-microinjected
oocytes were in interphase with a pronucleus (B, D). Transmission
(A, B) and confocal images (C, D). Oocytes used for transmission
and immunofluorescence were different. Microtubules are shown
in green and chromosomes in red.FIG. 6. Effect of cyclin B1 antisense RNA concentration on first
PB extrusion and entry into the second meiotic M phase. The
CBA/Kw oocytes were microinjected at the GV stage with different
concentrations of antisense RNA (1.5–5 A.U.) and were washed
from dbcAMP 4–5 h later. The difference between the groups of
oocytes microinjected with 1.5 and 5 A.U. of cyclin B1 antisense
RNA is statistically significant (P 5 0.02 using the unpaired
elch t test). The differences between the groups of oocytes
microinjected with 1.5 and 3 A.U. or 3 and 5 A.U. of cyclin B1
antisense RNA are statistically not significant (P 5 0.31 and P 5.14, respectively).
s of reproduction in any form reserved.
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408 Ledan et al.B1 mRNA, and not to a technical problem, another
mRNA whose translation has to be inhibited almost
completely to show a phenotype in mouse oocytes was
used. The analysis of mutant Mos2/2 mice has shown that
MOS is not required for GVBD and first PBE, but is
absolutely required for the arrest in metaphase II (Col-
ledge et al., 1994; Verlhac et al., 1996). The synthesis of
this protein has to be almost completely inhibited from
the beginning of meiotic maturation in order to avoid the
activation of the MOS/ . . . /MAP kinase (MAPK) path-
way that is responsible for the metaphase arrest: MAPK
activation takes place 2 h after GVBD, when only about
10% of the total amount of MOS is synthesized (Verlhac
et al., 1996). The extrusion of the second polar body takes
place in 75% of Mos2/2 oocytes (Verlhac et al., 1996).
hen we microinjected the full-length Mos antisense
RNA, we observed 32% of second polar body extrusion
Table 5). Thus, injection of the Mos antisense was able to
lock almost completely the expression of the MOS
rotein in one third of the oocytes. In addition, to get this
ffect, inhibition of MOS synthesis had to start from the
eginning of the first meiotic M phase.
FIG. 7. Effect of cyclin B1 antisense mRNA microinjection (5
A.U.) on H1 kinase activity during the first 5 h of meiotic
maturation (A) and after polar body extrusion (B) in CBA/Kw
oocytes. Ten oocytes per sample were used for the H1 kinase assay.
FIG. 8. Cyclin B1 levels in CBA oocytes microinjected with
cyclin B1 antisense RNA 6 h after GVBD. In (B), oocytes were
incubated in 10 mg/ml nocodazole starting 5 h after GVBD. Lysates
ere analyzed by immunoblotting using an anti-cyclin B1 anti-
ody. Groups of 80 (A) or 60 (B) oocytes. g
Copyright © 2001 by Academic Press. All rightAll these results suggest that, in contrast to the Mos
RNA, the cyclin B1 mRNA is protected until the end of
he first meiotic M phase in the mouse oocyte.
FIG. 9. (A) Schematic representation of the full-length cyclin B1
cDNA and different cyclin B1 antisense RNAs produced. (B) Effect
of the microinjection of the different cyclin B1 antisense RNAs (5
A.U.) on meiotic maturation in CBA/Kw oocytes. The oocytes were
injected at the GV stage and washed from dbcAMP 4–5 h later.
TABLE 5
Effect of c-Mos Antisense Injection on Meiotic Maturation in
Swiss Oocytes
Microinjected
antisense
RNA
% GVBD
(mean 6 SD)
% PBE 1
(mean 6 SD)
% PBE 2
(mean 6 SD)
n
(Expt)a
Control (none) 95 6 5 93.6 6 2 0 62 (2)
c-Mos 94.4 6 5.5 85.7 6 2 32 6 3 55 (2)
Note. Oocytes were microinjected at the GV stage and washed
from dbcAMP 4 h later.
a Number of oocytes. Number of experiments in each group is
iven in parentheses.
s of reproduction in any form reserved.
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Although cyclin B2 is not required for mouse develop-
ment and meiotic maturation (Brandeis et al., 1998), the
cyclin B2 mRNA is present in the immature oocytes
(Chapman and Wolgemuth, 1993). We confirmed by RT-
PCR that the cyclin B2 mRNA was present in GV and in M
II oocytes (Fig. 10). To test for a possible role of cyclin B2 in
meiotic maturation of the mouse oocyte, we microinjected
cyclin B2-A(n) mRNA into KE oocytes. The oocytes re-
sumed meiosis and extruded their first PB as the controls
(Table 6). In the presence of dbcAMP, cyclin B2-A(n) mRNA
induced GVBD more efficiently than cyclin B1-A(n) mRNA
(67% 6 10 versus 36.8% 6 6.2). Moreover, 80% of the
oocytes broke down their GV during the first 2.5 h follow-
ing microinjection versus 36.8% for the oocytes microin-
jected with cyclin B1-A(n) mRNA. However, the oocytes
microinjected with cyclin B2-A(n) mRNA that resumed
meiosis in dbcAMP extruded the first polar bodies almost
normally (64.8% 6 0.6) in contrast to the oocytes microin-
jected with cyclin B1-A(n) mRNA which were mostly
blocked in M I (16.7% 6 4.0 of PBE; Table 7). Thus
overexpression of cyclin B2 very efficiently overcomes the
dbcAMP block but does not induce an M I arrest.
DISCUSSION
In this work, we attempted to modify the level of cyclin
B during the maturation of the mouse oocyte by overex-
TABLE 6
Effect of Cyclin B2-A(n) mRNA Injection on Meiosis Resumption
Microinjected mRNA
% GVBD
(mean 6 SD)
% P
(mean 6
Control 82.8 6 10.9 62.3 6
Cyclin B2-A(n) 93 6 9.8 94.3 6
Note. Oocytes were microinjected at the GV stage and immedia
a Using the nonparametric Mann–Whitney test.
FIG. 10. Expression of the cyclin B1 and B2 mRNAs during
eiotic maturation in CBA/Kw oocytes. The products of polymer-
se chain reaction on reverse-transcribed mRNAs (RT1) were
nalyzed on a 2% agarose gel. RT2 corresponds to controls where
the reverse transcription step was omitted.b Number of oocytes. Number of experiments in each group is given
Copyright © 2001 by Academic Press. All rightressing or inhibiting the synthesis of cyclin B1 in KE and
n CBA/Kw oocytes, respectively. We observed that overex-
ression of cyclin B1 had many consequences on meiotic
aturation. First the microinjected oocytes were able to
ypass the dbcAMP-induced GV block. Second, cyclin B1-
(n) mRNA-microinjected oocytes presented two pheno-
ypes: most (60%) were blocked in MI while the others
xtruded their first polar bodies in advance.
The use of antisense mRNAs to inhibit cyclin B1 synthe-
is suggested that the endogenous cyclin B1 mRNAs were
rotected until the end of the first meiotic M phase.
evertheless, cyclin B1 synthesis was inhibited at the
etaphase/anaphase transition since polar body extrusion
as accelerated and oocytes were not able to reactivate
PF to enter into the second meiotic M phase.
Control of GVBD
In mouse oocytes, new protein synthesis is not necessary
for GVBD (Clarke and Masui, 1983; Stern and Wassarman,
1973) although cyclin B is synthesized at a low level in
mouse oocytes at the GV stage (Hampl and Eppig, 1995b;
Winston, 1997). It is thought that GVBD in mouse oocytes
is due to the dephosphorylation of a small pool of pre-MPF
(Choi et al., 1991, 1992).
Cyclin B1 mRNA-microinjected oocytes were able to
bypass the dbcAMP-induced GV block. Two hypotheses
can explain how cyclin B1 translation is able to bypass this
block. First, the overexpression of cyclin B1 could lead to
the formation of MPF that is not inactivated by phosphor-
ylation. Second, it could activate the cdc25 phosphatase
that dephosphorylates the pool of pre-MPF. We favor the
first hypothesis since overexpression of cyclin B1 over-
comes the orthovanadate-induced GV block that is thought
to be due to inhibition of cdc25 phosphatase (64% of
oocytes injected with cyclin B1-A(n) mRNA (n 5 41)
underwent GVBD in the presence of 2 mM orthovanadate
while only 7% (n 5 44) of the control oocytes resumed
meiosis) (Choi et al., 1992).
Our results suggest also that the size of the poly(A) tail is
esponsible for the level of cyclin B1 translation since only
he mRNAs with a long poly(A) tail were able to induce the
esumption of meiosis in the presence of dbcAMP. These
esults are in agreement with those of Tay et al. (2000)
irst Polar Body Extrusion in KE Oocytes
) Pa GVBD Pa PBE n (Expt)b
0.07 (NS) 0.03 (NS) 109 (6)
114 (6)
washed from dbcAMP.and F
BE
SD
17.7
8
telyin parentheses.
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410 Ledan et al.showing that polyadenylation of cyclin B1 mRNA is re-
quired for translation activation during mouse oocyte
maturation. For many mRNAs, the addition of A residues
promotes translational activation. For example, polyadenyl-
ation of Mos mRNA in Xenopus and in mouse oocytes is
equired for meiotic maturation (Gebauer et al., 1994;
heets et al., 1994). Oocyte injection studies have demon-
trated that the activation of tissue-type plasminogen acti-
ator in the mouse is also regulated by the number of 39
denylated residues (Huarte et al., 1992; Vassalli et al.,
989).
Progression of Meiotic Maturation and Exit from
the First M Phase
In the absence of protein synthesis, GVBD takes place but
the oocyte does not progress through meiosis I: the meiotic
spindle does not form and MPF activity drops in 3–4 h to a
low level (Polanski et al., 1998; Clarke and Masui, 1983).
Earlier studies have shown that, during the first meiotic M
phase, the level of cyclin B1 synthesis in CBA/Kw oocytes
is higher than that in KE oocytes and that MPF activation is
slower in KE oocytes (Polanski et al., 1998). All these
ifferences are responsible for the delayed PBE in KE oo-
ytes since the microinjection of polyadenylated cyclin B1
RNA in KE oocytes increases the level of MPF activity
nd speeds up PBE (Polanski et al., 1998).
In the experiments described above, we observed that the
cceleration of PBE is correlated with the size of the poly(A)
ail, suggesting that the longer the poly(A) tail, the more
yclin B1 synthesis. Recent studies have shown that the
ength of the poly(A) tail of cyclin B1 mRNA increases
rogressively during meiotic maturation, moderately be-
ween GV to M I (100 nucleotides) and more importantly
250 nucleotides) between M I and M II (Tay et al., 2000).
his increase coincides with the progressive rise of cyclin
1 synthesis during meiotic maturation (Hampl and Eppig,
995a; Winston, 1997). We conclude that the level of
ranslation of the cyclin B1 through the length of the
oly(A) tail controls the timing of the first M phase.
Another interesting observation was made in oocytes
TABLE 7
Effect of Cyclin B2-A(n) mRNA Injection on Meiosis Resumption
and First Polar Body Extrusion in KE Oocytes in the Presence
of dbcAMP
Microinjected mRNA
% GVBD
(mean 6 SD)
% PBE
(mean 6 SD) n (Expt)a
Control (none) 0 0 80 (4)
Cyclin B2-A(n) 67 6 10 64.8 6 9.8 83 (4)
Cyclin B1-A(n) 36.8 6 6.3 16.7 6 3.8 277 (6)
a Number of oocytes. Number of experiments in each group is
iven in parentheses.hat expressed very high levels of cyclin B1 (those able to c
Copyright © 2001 by Academic Press. All rightvercome the dbcAMP block): most of them never extruded
heir first PB even 12 h after the normal time of PBE. This
ould be due to the inability of these oocytes to degrade
nough cyclin B1 to reach the threshold of MPF activity
equired for exit from M phase and to the fact that degra-
ation can only occur during a given period of time once it
as started. When we followed the synthesis and the
egradation of cyclin B1–GFP in oocytes that extruded their
rst polar bodies, we observed that cyclin B1–GFP started to
e degraded 2 h before PBE. In oocytes that did not extrude
heir first polar bodies, we observed that degradation of
yclin B1–GFP was going on during a limited period of time
about 4 h) and that the minimum level of cyclin B1
bserved in controls was not reached. Then, in both groups
f oocytes, when cyclin degradation was switch off, an
ncrease in cyclin B1–GFP was observed. This was followed
y a steady state that most likely corresponds to the
quilibrium between synthesis and degradation that was
reviously described in Kubiak et al. (1993).
The Protection of the Cyclin B1 mRNA to the
Antisense
To test the effect of inhibition of cyclin B1 synthesis on
maturation we used the antisense technique. Surprisingly
the CBA/Kw oocytes microinjected with cyclin B1 anti-
sense mRNA progressed trough the first meiotic M phase
normally and extruded their first polar bodies although they
did so earlier than the control oocytes. However, in contrast
to the control oocytes that entered into the second meiotic
M phase, the microinjected oocytes entered into interphase
with a low MPF activity after PBE. Since we know that
cyclin B synthesis is required for the progression of the first
meiotic M phase, our observation suggests that antisense
mRNA is active only at the end of the first meiotic M
phase.
An antisense against the 59 region of the globin mRNA in
frog oocyte is sufficient to inhibit its synthesis (Melton,
1985), while an antisense RNA directed against the 39
noncoding region of the tPA (tissue-type plasminogen acti-
vator) prevents the activation of this dormant mRNA in
mouse oocytes (Strickland et al., 1988). In our experiments,
he microinjection of antisense mRNA with different sizes
nd directed against different regions of the cyclin B1
RNA had the same effect as the full-length antisense.
hus, this late accessibility of the endogenous cyclin B1
RNA to the antisense was not due to the long size of the
ntisense that could have difficulties hybridizing with the
ndogenous cyclin B1 mRNA. This suggests a masking
ffect that protects the mRNA until the end of the first
eiotic M phase in the mouse oocyte. Tay et al. demon-
trated that the mouse cyclin B1–CPEB (cytoplasmic poly-
denylation element binding protein) binds the ACE (ad-
nylation cytoplasmic element) at the GV stage and
epressed cyclin B1 translation (Tay et al., 2000). CPEB is
hosphorylated during the first meiotic M phase. This
ould modify the accessibility of cyclin B1 mRNA. We
s of reproduction in any form reserved.
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411Cyclin B Metabolism and Meiotic Maturationpropose that at the end of the first meiotic M phase, cyclin
B1 mRNA becomes accessible to the antisense leading to an
inhibition of cyclin B1 synthesis. This would speed up
cyclin B1 degradation (because no cyclin B1 synthesis
would occur at that time) and lead to a slight acceleration of
PBE.
What Is the Role of Cyclin B2 during Meiotic
Maturation?
Very little is known about the role of the different cyclin
Bs during meiotic maturation in vertebrates and the pres-
ence of different cyclin Bs raises a question. In Rana
aponica cyclin B1 or B2 is necessary and sufficient to
nduce GVBD (Ihara et al., 1998). In Xenopus oocytes, these
two cyclins seem to be expressed and complexed with cdks
differently during meiotic maturation. They are destroyed
with different kinetics in anaphase: cyclin B2 is degraded
earlier than cyclin B1 (Kobayashi et al., 1991; Minshull et
al., 1989). Cyclin B1 and B2 are coexpressed in the majority
of the dividing cell although the intracellular distribution of
the two cyclin Bs is different in human cultured cells:
cyclin B1 localizes to the microtubules and cyclin B2 to the
golgi apparatus in interphase. Cyclin B1, but not cyclin B2,
enters in the nucleus at the G2/M transition and is found on
the spindle at metaphase (Gallant and Nigg, 1992; Jackman
et al., 1995; Ookata et al., 1992; Pines and Hunter, 1991).
All these differences suggest different roles for these two
cyclin Bs, both in meiosis and in mitosis.
In mouse oocytes, both cyclin B1 and B2 transcripts are
present during meiotic maturation (Chapman and Wolge-
muth, 1992, 1993, and our work). We were able to detect the
presence of cyclin B2 during the M II arrest (data not
shown), although the sensitivity of the assay was very poor
since more than 400 oocytes were required to get a signal,
making a study of the expression of this protein during
meiotic maturation unworkable. However, mice lacking
functional cyclin B2 develop normally and are fertile
whereas the nullizigous B1 mice are embryonic lethal
(Brandeis et al., 1998). This indicates that meiotic matura-
tion can take place in the absence of cyclin B2 and would
explain the lack of effects of the cyclin B2 antisense.
However, the overexpression of cyclin B2 gave us some
interesting results: cyclin B2 was more efficient than cyclin
B1 in inducing GVBD in the presence of dbcAMP but was
not able to block polar body extrusion. This argues also for
different roles of cyclin B1 and B2 during meiosis. Recent
studies in Xenopus oocytes suggested that the correct
localization of cyclin B2, but not that of cyclin B1, is
essential for bipolar spindle formation (Yoshitome et al.,
1998). However, in mouse oocytes, cyclin B2 does not seem
to play a role in the setting up of a bipolar structure since
maturation is normal in oocytes from mice lacking cyclin
B2 (Brandeis et al., 1998), which implies that a functional
pindle was formed. Thus it is possible that cyclin B2 plays
specific role in the entry into meiotic M phase (although,t could be functionally replaced by cyclin B1).
Copyright © 2001 by Academic Press. All rightTaken together, our data demonstrate that the rates of
yclin B synthesis and degradation determine the timing of
he major events taking place during meiotic maturation of
he mouse oocyte. Although some progress has been made
n the characterization of the molecular mechanisms con-
rolling cyclin B metabolism during meiotic maturation of
he mouse oocyte (Barkoff et al., 2000; de Moor and Richter,
999; Kubiak et al., 1993; Polanski et al., 1998; Tay et al.,
000), more work is still required to fully understand them.
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